Topic analysis

UK drug exports to US spared tariffs under deal critics say will cost NHS billions

The UK and US have agreed to a drug pricing partnership that exempts UK drug exports from US tariffs and allows the NHS to pay more for certain treatments, such as two newly approved cancer drugs. Critics argue the deal will cost the NHS billions annually and was made without parliamentary scrutiny.